RECRUITING

C-Raven, a Virtual Tobacco Cessation Intervention in the Community

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In low-income housing units in Baltimore, the investigators propose to conduct a pilot two-arm hybrid type 1 effectiveness-implementation RCT comparing a) an avatar-delivered computerized intervention (CI) for tobacco cessation augmented with CHW support and navigation to lung cancer screening to b) a waitlist control. With a sample of participants from public housing units (N=30), the investigators will collect data on feasibility of recruitment, intervention engagement and completion, and short-term smoking cessation outcomes. Individuals will be assessed at baseline, 1 month, 3 months, and 6 months. At the 3-month time point, the investigators will conduct interviews with a subset of pilot participants to collect qualitative data on intervention acceptability.

Official Title

C-Raven: Pilot Randomized Controlled Trial (RCT) of an Avatar-delivered Computerized Intervention for Tobacco Cessation With Community Health Worker Linkage to Lung Cancer Screening in Baltimore City

Quick Facts

Study Start:2024-10-30
Study Completion:2025-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06545669

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 50 or older Current tobacco use with \>100 cigarettes smoked in their lifetime
  2. * English speaking (intervention currently in English only and housing units are in largely English-speaking neighborhoods)
  3. * Considering smoking cessation
  4. * Planning to remain in current housing unit for 9 months
  1. * Current use of pharmacological treatment for tobacco cessation
  2. * Contraindication to nicotine replacement therapy
  3. * Current engagement in formal smoking cessation program
  4. * Major cognitive or psychiatric impairment
  5. * Severe hearing impairment
  6. * Investigator discretion

Contacts and Locations

Study Contact

Alejandra Ellison-Barnes, MD
CONTACT
410-614-1135
aelliso6@jhmi.edu
Heidi Hutton, PhD
CONTACT
(443) 287-2874
hhutton@jhmi.edu

Principal Investigator

Alejandra Ellison-Barnes, MD
PRINCIPAL_INVESTIGATOR
Johns Hopkins School of Medicine

Study Locations (Sites)

Johns Hopkins University School of Medicine
Baltimore, Maryland, 21205
United States

Collaborators and Investigators

Sponsor: Johns Hopkins University

  • Alejandra Ellison-Barnes, MD, PRINCIPAL_INVESTIGATOR, Johns Hopkins School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-30
Study Completion Date2025-06

Study Record Updates

Study Start Date2024-10-30
Study Completion Date2025-06

Terms related to this study

Additional Relevant MeSH Terms

  • Tobacco Dependence